Literature DB >> 16271055

Recognition and management of Staphylococcus aureus toxin-mediated disease.

R J Murray1.   

Abstract

The ubiquitous human pathogen Staphylococcus aureus is capable of producing a formidable range of extracellular toxins that can have significant deleterious effects on the host. Toxic shock syndrome (TSS) results from infection or colonization with a strain of S. aureus that produces staphylococcal enterotoxin(s). The key features of TSS are widespread erythroderma occurring in association with profound hypotension and multiple organ dysfunction. As morbidity and mortality from TSS are appreciable, early recognition of TSS combined with intensive supportive management is critical. Staphylococcal foodborne disease (SFD) is caused by contamination of food during preparation or serving by preformed S. aureus enterotoxin(s). Symptom-onset is abrupt and the disease may be severe enough to warrant hospitalization, but it is usually self-limiting and does not require specific antistaphylococcal therapy. Staphylococcal scalded skin syndrome (SSSS) results from colonization or infection with a strain of S. aureus that produces epidermolytic toxin(s). SSSS ranges in severity from trivial focal skin blistering to extensive, life-threatening exfoliation. This review discusses the epidemiology, pathogenesis, diagnosis, and management of TSS, SFD and SSSS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271055     DOI: 10.1111/j.1444-0903.2005.00984.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  32 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

2.  Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering.

Authors:  Cory L Simpson; Shin-ichiro Kojima; Victoria Cooper-Whitehair; Spiro Getsios; Kathleen J Green
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

3.  Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor.

Authors:  Govindarajan Rajagopalan; Ashenafi Y Tilahun; Yan W Asmann; Chella S David
Journal:  Physiol Genomics       Date:  2009-03-31       Impact factor: 3.107

4.  An innovative local treatment for staphylococcal scalded skin syndrome.

Authors:  E Mueller; M Haim; T Petnehazy; B Acham-Roschitz; M Trop
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-01       Impact factor: 3.267

5.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

6.  A single-stranded DNA aptamer that selectively binds to Staphylococcus aureus enterotoxin B.

Authors:  Jeffrey A DeGrasse
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

7.  Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Eric V Marietta; Tsung-Teh Wu; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

8.  Detrimental effect of the proteasome inhibitor, bortezomib in bacterial superantigen- and lipopolysaccharide-induced systemic inflammation.

Authors:  Ashenafi Y Tilahun; Jayne E Theuer; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Mol Ther       Date:  2010-04-06       Impact factor: 11.454

9.  Anti-Staphylococcal Enterotoxinogenesis of Lactococcus lactis in Algerian Raw Milk Cheese.

Authors:  Fatiha Tetili; Farida Bendali; Josette Perrier; Djamila Sadoun
Journal:  Food Technol Biotechnol       Date:  2017-12       Impact factor: 3.918

Review 10.  Looking toward basic science for potential drug discovery targets against community-associated MRSA.

Authors:  Michael Otto
Journal:  Med Res Rev       Date:  2010-01       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.